Trademarkia Logo

Canada

C$
CorEngager
FORMALIZED

on 6 Mar 2025

Last Applicant/ Owned by

Corregene Biotechnology Co., Ltd.

Room 317-2, 3rd Floor, Building 1, No.1 Nengyuan East Road, Shahe Town,Changping DistrictBeijing

CN

Serial Number

2384132 filed on 20th Nov 2024

CorEngager

Trademark usage description

protein [raw material]; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterin Read More

Classification Information


Class [001]
Protein [raw material]; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biological preparations for use in cell cultures, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic preparations for research laboratory use; biological preparations, other than for medical or veterinary purposes; biochemical reagents, other than for medical purposes; cell culture reagents for scientific or research purposes.


Classification kind code

12

Class [005]
Pharmaceutical preparations; anti-cancer preparations; diagnostic preparations for medical or veterinary purpose for diagnosing and/or treating tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic diseases, immune disorder, TORCH infections and immunoglobulin diseases, infectious diseases, immune disease and fibrosis diseases.; medicines for human purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; surgical implants comprised of living tissues; stem cells for medical purposes; vaccines; enzyme preparations for medical purposes for testing, analysis, diagnosis and treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic diseases, immune disorder, TORCH infections and immunoglobulin diseases, infectious diseases, immune disease and fibrosis diseases.; biological preparations for medical purposes for testing, analysis, diagnosis and treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic diseases, immune disorder, TORCH infections and immunoglobulin diseases, infectious diseases, immune disease and fibrosis diseases.


Classification kind code

12

Class [042]
Chemical research; chemical analysis; chemistry services, namely, chemistry research services related to biotechnology, pharmaceuticals, medicine & veterinary medicine chemicals and technologies, protein and protein technology, nucleic acid and nucleic acid technology; cosmetic research; bacteriological research; biological research; medical research; medical laboratory services; clinical trials.


Classification kind code

12

Mark Details


Serial Number

2384132

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 6th Mar 2025
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 6th Mar 2025
Formalized
Submitted for opposition 1
on 5th Mar 2025
Created
Submitted for opposition 30
on 20th Nov 2024
Filed
Submitted for opposition 228
on 20th Nov 2024
International Registration